List of Tables
Table 1. Global Alzheimer's Disease Drug Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Alzheimer's Disease Drug Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Alzheimer's Disease Drug Market Competitive Situation by Manufacturers in 2025
Table 4. Global Alzheimer's Disease Drug Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Alzheimer's Disease Drug Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Alzheimer's Disease Drug Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Alzheimer's Disease Drug Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Alzheimer's Disease Drug Average Price (USD/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Alzheimer's Disease Drug, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Alzheimer's Disease Drug, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Alzheimer's Disease Drug, Product Types and Applications
Table 12. Global Key Manufacturers of Alzheimer's Disease Drug, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Alzheimer's Disease Drug Companies by Tier (Tier 1, Tier 2, Tier 3), based on Alzheimer's Disease Drug Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Alzheimer's Disease Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Alzheimer's Disease Drug Sales by Region (K Units), 2021–2026
Table 18. Global Alzheimer's Disease Drug Sales Market Share by Region (2021–2026)
Table 19. Global Alzheimer's Disease Drug Sales by Region (K Units), 2027–2032
Table 20. Global Alzheimer's Disease Drug Sales Market Share by Region (2027–2032)
Table 21. Global Alzheimer's Disease Drug Revenue by Region (US$ Million), 2021–2026
Table 22. Global Alzheimer's Disease Drug Revenue Market Share by Region (2021–2026)
Table 23. Global Alzheimer's Disease Drug Revenue by Region (US$ Million), 2027–2032
Table 24. Global Alzheimer's Disease Drug Revenue Market Share by Region (2027–2032)
Table 25. North America Alzheimer's Disease Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Alzheimer's Disease Drug Sales by Country (K Units), 2021–2026
Table 27. North America Alzheimer's Disease Drug Sales by Country (K Units), 2027–2032
Table 28. North America Alzheimer's Disease Drug Revenue by Country (US$ Million), 2021–2026
Table 29. North America Alzheimer's Disease Drug Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Alzheimer's Disease Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Alzheimer's Disease Drug Sales by Country (K Units), 2021–2026
Table 32. Europe Alzheimer's Disease Drug Sales by Country (K Units), 2027–2032
Table 33. Europe Alzheimer's Disease Drug Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Alzheimer's Disease Drug Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Alzheimer's Disease Drug Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Alzheimer's Disease Drug Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Alzheimer's Disease Drug Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Alzheimer's Disease Drug Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Alzheimer's Disease Drug Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Alzheimer's Disease Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Alzheimer's Disease Drug Sales by Country (K Units), 2021–2026
Table 42. Latin America Alzheimer's Disease Drug Sales by Country (K Units), 2027–2032
Table 43. Latin America Alzheimer's Disease Drug Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Alzheimer's Disease Drug Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Alzheimer's Disease Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Alzheimer's Disease Drug Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Alzheimer's Disease Drug Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Alzheimer's Disease Drug Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Alzheimer's Disease Drug Revenue by Country (US$ Million), 2027–2032
Table 50. Global Alzheimer's Disease Drug Sales (K Units) by Type (2021–2026)
Table 51. Global Alzheimer's Disease Drug Sales (K Units) by Type (2027–2032)
Table 52. Global Alzheimer's Disease Drug Sales Market Share by Type (2021–2026)
Table 53. Global Alzheimer's Disease Drug Sales Market Share by Type (2027–2032)
Table 54. Global Alzheimer's Disease Drug Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Alzheimer's Disease Drug Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Alzheimer's Disease Drug Revenue Market Share by Type (2021–2026)
Table 57. Global Alzheimer's Disease Drug Revenue Market Share by Type (2027–2032)
Table 58. Global Alzheimer's Disease Drug Price (USD/Unit) by Type (2021–2026)
Table 59. Global Alzheimer's Disease Drug Price (USD/Unit) by Type (2027–2032)
Table 60. Global Alzheimer's Disease Drug Sales (K Units) by Application (2021–2026)
Table 61. Global Alzheimer's Disease Drug Sales (K Units) by Application (2027–2032)
Table 62. Global Alzheimer's Disease Drug Sales Market Share by Application (2021–2026)
Table 63. Global Alzheimer's Disease Drug Sales Market Share by Application (2027–2032)
Table 64. Global Alzheimer's Disease Drug Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Alzheimer's Disease Drug Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Alzheimer's Disease Drug Revenue Market Share by Application (2021–2026)
Table 67. Global Alzheimer's Disease Drug Revenue Market Share by Application (2027–2032)
Table 68. Global Alzheimer's Disease Drug Price (USD/Unit) by Application (2021–2026)
Table 69. Global Alzheimer's Disease Drug Price (USD/Unit) by Application (2027–2032)
Table 70. Allergan Company Information
Table 71. Allergan Description and Business Overview
Table 72. Allergan Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 73. Allergan Alzheimer's Disease Drug Product
Table 74. Allergan Recent Developments/Updates
Table 75. Eisai Company Information
Table 76. Eisai Description and Business Overview
Table 77. Eisai Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 78. Eisai Alzheimer's Disease Drug Product
Table 79. Eisai Recent Developments/Updates
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 83. Novartis Alzheimer's Disease Drug Product
Table 84. Novartis Recent Developments/Updates
Table 85. Daiichi Sankyo Company Information
Table 86. Daiichi Sankyo Description and Business Overview
Table 87. Daiichi Sankyo Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 88. Daiichi Sankyo Alzheimer's Disease Drug Product
Table 89. Daiichi Sankyo Recent Developments/Updates
Table 90. Merz Pharma Company Information
Table 91. Merz Pharma Description and Business Overview
Table 92. Merz Pharma Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 93. Merz Pharma Alzheimer's Disease Drug Product
Table 94. Merz Pharma Recent Developments/Updates
Table 95. Pfizer Company Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 98. Pfizer Alzheimer's Disease Drug Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Johnson & Johnson Company Information
Table 101. Johnson & Johnson Description and Business Overview
Table 102. Johnson & Johnson Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 103. Johnson & Johnson Alzheimer's Disease Drug Product
Table 104. Johnson & Johnson Recent Developments/Updates
Table 105. Lundbeck Company Information
Table 106. Lundbeck Description and Business Overview
Table 107. Lundbeck Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 108. Lundbeck Alzheimer's Disease Drug Product
Table 109. Lundbeck Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Alzheimer's Disease Drug Distributors List
Table 113. Alzheimer's Disease Drug Customers List
Table 114. Alzheimer's Disease Drug Market Trends
Table 115. Alzheimer's Disease Drug Market Drivers
Table 116. Alzheimer's Disease Drug Market Challenges
Table 117. Alzheimer's Disease Drug Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Alzheimer's Disease Drug
Figure 2. Global Alzheimer's Disease Drug Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Alzheimer's Disease Drug Market Share by Type: 2025 & 2032
Figure 4. Donepezil Product Picture
Figure 5. Memantine Product Picture
Figure 6. Rivastigmine Product Picture
Figure 7. Others Product Picture
Figure 8. Global Alzheimer's Disease Drug Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Alzheimer's Disease Drug Market Share by Application: 2025 & 2032
Figure 10. Early to Moderate Stages
Figure 11. Moderate to Severe Stages
Figure 12. Global Alzheimer's Disease Drug Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Alzheimer's Disease Drug Market Size (US$ Million), 2021–2032
Figure 14. Global Alzheimer's Disease Drug Sales (K Units), 2021–2032
Figure 15. Global Alzheimer's Disease Drug Average Price (USD/Unit), 2021–2032
Figure 16. Alzheimer's Disease Drug Report Years Considered
Figure 17. Alzheimer's Disease Drug Sales Share by Manufacturers in 2025
Figure 18. Global Alzheimer's Disease Drug Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Alzheimer's Disease Drug Players: Market Share by Revenue in Alzheimer's Disease Drug in 2025
Figure 20. Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Alzheimer's Disease Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Alzheimer's Disease Drug Sales Market Share by Country (2021–2032)
Figure 23. North America Alzheimer's Disease Drug Revenue Market Share by Country (2021–2032)
Figure 24. U.S. Alzheimer's Disease Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Alzheimer's Disease Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Alzheimer's Disease Drug Sales Market Share by Country (2021–2032)
Figure 27. Europe Alzheimer's Disease Drug Revenue Market Share by Country (2021–2032)
Figure 28. Germany Alzheimer's Disease Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Alzheimer's Disease Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Alzheimer's Disease Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Alzheimer's Disease Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Alzheimer's Disease Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Alzheimer's Disease Drug Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Alzheimer's Disease Drug Revenue Market Share by Region (2021–2032)
Figure 35. China Alzheimer's Disease Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Alzheimer's Disease Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Alzheimer's Disease Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Alzheimer's Disease Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Alzheimer's Disease Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Alzheimer's Disease Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Indonesia Alzheimer's Disease Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Thailand Alzheimer's Disease Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Malaysia Alzheimer's Disease Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Alzheimer's Disease Drug Sales Market Share by Country (2021–2032)
Figure 45. Latin America Alzheimer's Disease Drug Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Alzheimer's Disease Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Alzheimer's Disease Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Alzheimer's Disease Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Colombia Alzheimer's Disease Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Alzheimer's Disease Drug Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Alzheimer's Disease Drug Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Alzheimer's Disease Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Alzheimer's Disease Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Alzheimer's Disease Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Alzheimer's Disease Drug by Type (2021–2032)
Figure 56. Global Revenue Market Share of Alzheimer's Disease Drug by Type (2021–2032)
Figure 57. Global Alzheimer's Disease Drug Price (USD/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Alzheimer's Disease Drug by Application (2021–2032)
Figure 59. Global Revenue Market Share of Alzheimer's Disease Drug by Application (2021–2032)
Figure 60. Global Alzheimer's Disease Drug Price (USD/Unit) by Application (2021–2032)
Figure 61. Alzheimer's Disease Drug Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
